| Sharon J Harris, CRNA | |
|
187 Millburn Ave, Ste 102, Millburn, NJ 07041-1845 | |
| (973) 346-7570 | |
| (973) 346-7527 |
| Full Name | Sharon J Harris |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 25 Years |
| Location | 187 Millburn Ave, Millburn, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063563195 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR05627800 (New Jersey) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 26NJ00208800 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Amsurg Mdsine Anesthesia Llc | 8729204334 | 4 |
News Archive
A complete skin grafting solution for burns and trauma surgery enabling flexibility of thin and thick skin grafts will be launched by Surtex Instruments at Hospitalar 2015.
Rustling leaves, light rain at the window, a quietly ticking clock - muffled sounds, just above the threshold of hearing.
A team of Cedars-Sinai investigators has developed a new technique for conducting cardiac magnetic resonance imaging tests that improves patient comfort, shortens testing time and has the potential to increase diagnostic accuracy and reliability.
University of Maryland researchers have explained, for the first time, why the linkage between the cell-regulating protein molecules called ubiquitins determines their function.
Aeolus Pharmaceuticals, Inc. announced today that it has completed a $1.65 million financing with several existing institutional shareholders, all of which are affiliates of Xmark Opportunity Partners, LLC. Under the terms of the financing, Aeolus received $1.65 million in gross proceeds in exchange for 5,892,857 Units (the "Units"), with each Unit comprised of one share of Aeolus Pharmaceuticals common stock, and a seven year warrant to purchase up to two additional shares of Aeolus Pharmaceuticals common stock at an initial exercise price of $0.28 per share, for a per Unit purchase price of $0.28.
› Verified 9 days ago
| Entity Name | Anesthesia Professionals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659346443 PECOS PAC ID: 0042297582 Enrollment ID: O20040702000303 |
News Archive
A complete skin grafting solution for burns and trauma surgery enabling flexibility of thin and thick skin grafts will be launched by Surtex Instruments at Hospitalar 2015.
Rustling leaves, light rain at the window, a quietly ticking clock - muffled sounds, just above the threshold of hearing.
A team of Cedars-Sinai investigators has developed a new technique for conducting cardiac magnetic resonance imaging tests that improves patient comfort, shortens testing time and has the potential to increase diagnostic accuracy and reliability.
University of Maryland researchers have explained, for the first time, why the linkage between the cell-regulating protein molecules called ubiquitins determines their function.
Aeolus Pharmaceuticals, Inc. announced today that it has completed a $1.65 million financing with several existing institutional shareholders, all of which are affiliates of Xmark Opportunity Partners, LLC. Under the terms of the financing, Aeolus received $1.65 million in gross proceeds in exchange for 5,892,857 Units (the "Units"), with each Unit comprised of one share of Aeolus Pharmaceuticals common stock, and a seven year warrant to purchase up to two additional shares of Aeolus Pharmaceuticals common stock at an initial exercise price of $0.28 per share, for a per Unit purchase price of $0.28.
› Verified 9 days ago
| Entity Name | Amsurg Mdsine Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932521366 PECOS PAC ID: 8729204334 Enrollment ID: O20140716001986 |
News Archive
A complete skin grafting solution for burns and trauma surgery enabling flexibility of thin and thick skin grafts will be launched by Surtex Instruments at Hospitalar 2015.
Rustling leaves, light rain at the window, a quietly ticking clock - muffled sounds, just above the threshold of hearing.
A team of Cedars-Sinai investigators has developed a new technique for conducting cardiac magnetic resonance imaging tests that improves patient comfort, shortens testing time and has the potential to increase diagnostic accuracy and reliability.
University of Maryland researchers have explained, for the first time, why the linkage between the cell-regulating protein molecules called ubiquitins determines their function.
Aeolus Pharmaceuticals, Inc. announced today that it has completed a $1.65 million financing with several existing institutional shareholders, all of which are affiliates of Xmark Opportunity Partners, LLC. Under the terms of the financing, Aeolus received $1.65 million in gross proceeds in exchange for 5,892,857 Units (the "Units"), with each Unit comprised of one share of Aeolus Pharmaceuticals common stock, and a seven year warrant to purchase up to two additional shares of Aeolus Pharmaceuticals common stock at an initial exercise price of $0.28 per share, for a per Unit purchase price of $0.28.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sharon J Harris, CRNA Po Box 551420, Fort Lauderdale, FL 33355-1420 Ph: (800) 243-3839 | Sharon J Harris, CRNA 187 Millburn Ave, Ste 102, Millburn, NJ 07041-1845 Ph: (973) 346-7570 |
News Archive
A complete skin grafting solution for burns and trauma surgery enabling flexibility of thin and thick skin grafts will be launched by Surtex Instruments at Hospitalar 2015.
Rustling leaves, light rain at the window, a quietly ticking clock - muffled sounds, just above the threshold of hearing.
A team of Cedars-Sinai investigators has developed a new technique for conducting cardiac magnetic resonance imaging tests that improves patient comfort, shortens testing time and has the potential to increase diagnostic accuracy and reliability.
University of Maryland researchers have explained, for the first time, why the linkage between the cell-regulating protein molecules called ubiquitins determines their function.
Aeolus Pharmaceuticals, Inc. announced today that it has completed a $1.65 million financing with several existing institutional shareholders, all of which are affiliates of Xmark Opportunity Partners, LLC. Under the terms of the financing, Aeolus received $1.65 million in gross proceeds in exchange for 5,892,857 Units (the "Units"), with each Unit comprised of one share of Aeolus Pharmaceuticals common stock, and a seven year warrant to purchase up to two additional shares of Aeolus Pharmaceuticals common stock at an initial exercise price of $0.28 per share, for a per Unit purchase price of $0.28.
› Verified 9 days ago
Suzanna P. Miller, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 187 Millburn Ave, Millburn, NJ 07041 Phone: 973-467-1466 Fax: 973-467-1422 | |
Susan Petri, APN CRNA RN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 187 Millburn Ave, Suite 101, Millburn, NJ 07041 Phone: 973-467-1466 | |
Mrs. Kathleen Glass, MS, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 187 Millburn Ave, Millburn, NJ 07041 Phone: 973-467-1466 Fax: 973-467-1422 | |
Julie George, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 187 Millburn Ave, Millburn, NJ 07041 Phone: 973-671-0555 Fax: 973-671-0557 |